Abstract:ABSTRACT Treatments with antibiotic combinations are becoming increasingly important even though the supposed clinical benefits of combinations are, in many cases, unclear. Here, we systematically examined how several clinically used antibiotics interact and affect the antimicrobial efficacy against five especially problematic Gram-negative pathogens. A total of 232 bacterial isolates were tested against different pairwise antibiotic combinations spanning five classes, and the ability of all combinations in inhibiting growth was quantified. Descriptive statistics, principal component analysis (PCA), and Spearman’s rank correlation matrix were used to determine the correlations between the different combinations on interaction outcome. Several important conclusions can be drawn from the 696 examined interactions. Firstly, within a species, the interactions are in general conserved but can be isolate-specific for a given antibiotic combination and can range from antagonistic to synergistic. Secondly, additive and antagonistic interactions are the most common observed across species and antibiotics, with 87.1% of isolate-antibiotic combinations being additive, 11.6% antagonistic, and only 0.3% showing synergy. These findings suggest that to achieve the highest precision and efficacy of combination therapy, not only isolate-specific interaction profiling ought to be routinely performed, in particular to avoid using drug combinations that show antagonistic interaction and an expected associated reduction in efficacy, but also discovering rare and potentially valuable synergistic interactions. IMPORTANCE Antibiotic combinations are often used to treat bacterial infections, which aim to increase treatment efficacy and reduce resistance evolution. Typically, it is assumed that one specific antibiotic combination has the same effect on different isolates of the same species, i.e., the interaction is conserved. Here, we tested this idea by examining how several clinically used antibiotics interact and affect the antimicrobial efficacy against several bacterial pathogens. Our results show that, even though within a species the interactions are often conserved, there are also isolate-specific differences for a given antibiotic combination that can range from antagonistic to synergistic. These findings suggest that isolate-specific interaction profiling ought to be performed in clinical microbiology routine to avoid using antagonistic drug combinations that might reduce treatment efficacy.

Studies on the Interaction Between Antibiotics and DNA

Study on interaction between ampicillin antibody and detection interfering proteins by computer aided protein-protein docking for biosensor interesting

A Computerized Protein–protein Interaction Modeling Study of Ampicillin Antibody Specificity in Relation to Biosensor Development

QSAR Study on the Interactions Between Antibiotic Compounds and DNA by a Hybrid Genetic-Based Support Vector Machine

Novel prediction of interactive mode between antibiotics and their DNA/protein targets based on the antibiotic structure parameters.

Results of Molecular Docking As Descriptors to Predict Human Serum Albumin Binding Affinity.

In Silico Studies of Indole Derivatives as Antibacterial Agents

Investigation into the Quantitative Structure‐Biotoxicity Relationship of Antibiotics and their Estrogenic Receptor Disruption Effects

A High-Throughput Percentage-of-binding Strategy to Measure Binding Energies in DNA-protein Interactions: Application to Genome-Scale Site Discovery.

Identification of a Preferred Set of Molecular Descriptors for Compound Classification Based on Principal Component Analysis

Antibiotic Combinations Prediction Based on Machine Learning to Multicentre Clinical Data and Drug Interaction Correlation.

Investigation of bacterial DNA gyrase Inhibitor classification models and structural requirements utilizing multiple machine learning methods

Within-species variability of antibiotic interactions in Gram-negative bacteria

Prediction of Antibacterial Compounds by Machine Learning Approaches

Antibacterial Drug Leads: DNA and Enzyme Multitargeting.

Studies on the antibacterial activities and molecular mechanism of GyrB inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulation

Dna Binding and Recognition by Binuclear Transition Metal Complexes

Quantitative Structure - Activity Relationship Model for Prediction of Genotoxic Potential for Quinolone Antibacterials

Free energy calculations reveal the interaction and stability of ligands in the vicinity of B-DNA dodecamer

Antibiotics as a selective driver for conjugation dynamics

Functional classification of drugs by properties of their pairwise interactions